CRISPR Therapeutics Unearned Premium on Insurance Contract (Quarterly) Insights

CRISPR Therapeutics AG (CRSP)

54.01 +0.55 (+1.03%) USD | NASDAQ | Feb 23, 16:00

53.75 -0.26 (-0.48%) After-Hours: 19:59

View Unearned Premium on Insurance Contract (Quarterly) for CRSP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Vertex Pharmaceuticals, Inc.	--
Beam Therapeutics, Inc.	--
Novartis AG	--
Recursion Pharmaceuticals, Inc.	--
EvoNext Holdings SA	--